Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US8338466B2 · kind B2 · utility
12Cited by
14References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2010 |
| Grant date | Dec 25, 2012 |
| Priority date | — |
| Expiry date | Aug 7, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.